492 related articles for article (PubMed ID: 4205524)
1. Increased clearance of antipyrine and d-propranolol after phenobarbital treatment in the monkey. Relative contributions of enzyme induction and increased hepatic blood flow.
Branch RA; Shand DG; Wilkinson GR; Nies AS
J Clin Invest; 1974 Apr; 53(4):1101-7. PubMed ID: 4205524
[TBL] [Abstract][Full Text] [Related]
2. Effect of butalbital and phenobarbital pretreatment on antipyrine clearance in the rat.
Tse FL; Chang T; Jaffe JM
Arch Int Pharmacodyn Ther; 1986 Feb; 279(2):181-94. PubMed ID: 3963935
[TBL] [Abstract][Full Text] [Related]
3. Increase in hepatic blood flow and d-propranolol clearance by glucagon in the monkey.
Branch RA; Shand DG; Nies AS
J Pharmacol Exp Ther; 1973 Dec; 187(3):581-7. PubMed ID: 4203721
[No Abstract] [Full Text] [Related]
4. Interactions of phenobarbital with propranolol in the dog. 2. Bioavailability, metabolism and pharmacokinetics.
Vu VT; Bai SA; Abramson FP
J Pharmacol Exp Ther; 1983 Jan; 224(1):55-61. PubMed ID: 6848749
[TBL] [Abstract][Full Text] [Related]
5. Hepatic artery flow and propranolol metabolism in perfused cirrhotic rat liver.
Le Couteur DG; Hickey H; Harvey PJ; Gready J; McLean AJ
J Pharmacol Exp Ther; 1999 Jun; 289(3):1553-8. PubMed ID: 10336552
[TBL] [Abstract][Full Text] [Related]
6. Beta-adrenergic blockade affects initial drug distribution due to decreased cardiac output and altered blood flow distribution.
Avram MJ; Krejcie TC; Henthorn TK; Niemann CU
J Pharmacol Exp Ther; 2004 Nov; 311(2):617-24. PubMed ID: 15197245
[TBL] [Abstract][Full Text] [Related]
7. Phenobarbital in the genetically obese Zucker rat. II. In vivo and in vitro assessments of microsomal enzyme induction.
Brouwer KL; Kostenbauder HB; McNamara PJ; Blouin RA
J Pharmacol Exp Ther; 1984 Dec; 231(3):654-9. PubMed ID: 6502519
[TBL] [Abstract][Full Text] [Related]
8. Effects of route of administration and blood flow on hepatic drug elimination.
Shand DG; Kornhauser DM; Wilkinson GR
J Pharmacol Exp Ther; 1975 Dec; 195(3):424-32. PubMed ID: 1195129
[TBL] [Abstract][Full Text] [Related]
9. Hemodynamic drug interactions.
Nies AS; Shand DG; Branch RA
Cardiovasc Clin; 1974; 6(2):43-53. PubMed ID: 4613462
[No Abstract] [Full Text] [Related]
10. Reduced hepatic clearance of propranolol induced by chronic carbon tetrachloride treatment in rats.
Iwamoto K; Watanabe J; Araki K; Satoh M; Deguchi N
J Pharmacol Exp Ther; 1985 Aug; 234(2):470-5. PubMed ID: 4020680
[TBL] [Abstract][Full Text] [Related]
11. Influence of rifampicin, phenobarbital and cimetidine on mixed function monooxygenase in extensive and poor metabolizers of debrisoquine.
Leclercq V; Desager JP; Horsmans Y; Van Nieuwenhuyze Y; Harvengt C
Int J Clin Pharmacol Ther Toxicol; 1989 Dec; 27(12):593-8. PubMed ID: 2613393
[TBL] [Abstract][Full Text] [Related]
12. On the antipyrine test in laboratory animals. Studies in the dog and monkey.
Vickers FF; Bowman TA; Dvorchik BH; Passananti GT; Hughes DM; Vesell ES
Drug Metab Dispos; 1989; 17(2):160-5. PubMed ID: 2565205
[TBL] [Abstract][Full Text] [Related]
13. Effects of chronic phenobarbital on verapamil disposition in humans.
Rutledge DR; Pieper JA; Mirvis DM
J Pharmacol Exp Ther; 1988 Jul; 246(1):7-13. PubMed ID: 3392664
[TBL] [Abstract][Full Text] [Related]
14. The hemodynamic effects of beta adrenergic blockade on the flow-dependent hepatic clearance of propranolol.
Nies AS; Evans GH; Shand DG
J Pharmacol Exp Ther; 1973 Mar; 184(3):716-20. PubMed ID: 4631471
[No Abstract] [Full Text] [Related]
15. Ranitidine alters antipyrine metabolism in control and phenobarbital-treated mice.
Espiritu-Quiza MF; Skinner MH; Blaschke TF
Methods Find Exp Clin Pharmacol; 1990 Nov; 12(9):631-6. PubMed ID: 2084458
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic profile of antipyrine in young rhesus monkeys (Macaca mulatta) with protein energy malnutrition.
Sharma B; Mehta S; Nain CK; Mathur VS
Drug Nutr Interact; 1985; 3(2):93-8. PubMed ID: 3921335
[TBL] [Abstract][Full Text] [Related]
17. Genetic control of the phenobarbital-induced shortening of plasma antipyrine half-lives in man.
Vesell ES; Page JG
J Clin Invest; 1969 Dec; 48(12):2202-9. PubMed ID: 5389794
[TBL] [Abstract][Full Text] [Related]
18. Alteration of the pharmacokinetics and metabolism of propranolol and antipyrine elicited by indwelling catheters in the rat.
Chindavijak B; Belpaire FM; De Smet F; Bogaert MG
J Pharmacol Exp Ther; 1988 Sep; 246(3):1075-9. PubMed ID: 3418510
[TBL] [Abstract][Full Text] [Related]
19. Effect of Fluosol-DA hemodilution on the kinetics of hepatically eliminated drugs.
Shrewsbury RP
Res Commun Chem Pathol Pharmacol; 1987 Mar; 55(3):375-96. PubMed ID: 3575876
[TBL] [Abstract][Full Text] [Related]
20. Intact hepatocyte theory of impaired drug metabolism in experimental cirrhosis in the rat.
Wood AJ; Villeneuve JP; Branch RA; Rogers LW; Shand DG
Gastroenterology; 1979 Jun; 76(6):1358-62. PubMed ID: 437433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]